Bodenstedt Matthias's Form 4 filing
MoonLake Immunotherapeutics (MLTX) · filed Jun 18, 2026
- Accession no.
- 0001213900-26-070259
- Filed
- Jun 18, 2026
- Trade date
- Jun 17-18, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $351.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bodenstedt MatthiasCIK 0001920545 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Class A ordinary shares, par value $0.0001 per share | SSaleDisposed | −15,082 | $19.68 | −$296,813.76 | 1,157,349 | Direct | |
| Jun 18, 2026 | Class A ordinary shares, par value $0.0001 per share | SSaleDisposed | −2,794 | $19.60 | −$54,762.4 | 1,154,555 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.